Shoulder and Hip Stiffness After 50: When Polymyalgia Rheumatica Needs a Rheumatologist

Margaret, 68, could not lift her arms high enough to fasten her bra. Two weeks earlier she had been gardening for hours; now she was rolling out of bed sideways because sitting up hurt across both shoulders and both hips. She assumed she had overdone it. Then she noticed the pattern: agony on waking, easing by lunchtime, back again by evening. Nothing about it matched a pulled muscle.

Her story is the classic opening chapter of polymyalgia rheumatica, or PMR, an inflammatory condition of later life that arrives fast, symmetrically and with a stiffness that outlasts any ordinary ache. The question people type into a search bar at 5 a.m. is not really “what is this?” but “who should I see, and how urgently?” That is what this article answers: polymyalgia rheumatica, when to see a rheumatologist, and when your family doctor is the right person to stay with.

The honest answer has layers. Most people never need a specialist. Some need one quickly. Knowing which group you are in matters more than any other single decision.

What is polymyalgia rheumatica, and why does it target shoulders and hips?

Polymyalgia rheumatica is an inflammatory rheumatic condition that causes pain and stiffness, most often in the shoulders, neck, upper arms, hips and thighs. The name is Greek for “pain in many muscles,” which is slightly misleading, because the muscles themselves are not the primary problem. Inflammation settles in the linings of joints and in the bursae, the small fluid-filled cushions around the shoulder and hip joints, and the discomfort is felt as a deep muscular ache (Mayo Clinic).

Three features set it apart from the everyday wear and tear that people over 50 tend to blame. First, it is symmetrical: both shoulders, both hips, not one sore knee. Second, it is worst after rest. NHS guidance describes stiffness on waking that lasts longer than 45 minutes, and many patients describe it lasting well into the morning. Third, it tends to come on quickly, over days to a couple of weeks, rather than creeping in over years.

The condition is almost never seen in people under 50, and the average age at onset is in the seventies (NHS). Women are affected roughly two to three times more often than men, and it is most common in people of Northern European ancestry (Mayo Clinic). None of these facts prove or disprove PMR in an individual; they simply explain why a doctor’s suspicion rises sharply when a woman in her late sixties describes exactly what Margaret described.

It also helps to say what PMR is not. It is not arthritis in the sense of worn cartilage, it is not fibromyalgia, and it is not a muscle disease. Blood tests that measure muscle breakdown are typically normal, a detail that becomes useful when a doctor is sorting one cause of pain from another.

How polymyalgia rheumatica works: what is actually happening inside the body

Nobody has yet pinned down the trigger. The best-supported explanation is that a genetic susceptibility meets an environmental spark, possibly a viral infection, and the immune system responds by producing inflammatory signaling proteins called cytokines, especially one named interleukin-6 (Cleveland Clinic). Those cytokines drive inflammation in the synovium, the thin membrane lining the shoulder and hip joints, and in the surrounding bursae and tendon sheaths.

That is why ultrasound or MRI of an affected shoulder often shows fluid around the biceps tendon and inflamed bursae rather than damaged cartilage. It is also why the pain radiates: an inflamed shoulder bursa hurts down the upper arm, and an inflamed hip bursa hurts into the thigh. Patients frequently insist the problem is “in the muscle,” and in terms of where it is felt, they are right.

The same inflammatory cascade explains the whole-body symptoms that so often accompany PMR: fatigue, low mood, mild fever, loss of appetite and unintended weight loss (MedlinePlus). Interleukin-6 acts on the liver to raise C-reactive protein, or CRP, and on the blood to raise the erythrocyte sedimentation rate, or ESR. Those two tests become the doctor’s window onto the process.

Understanding the mechanism also explains the treatment logic. Corticosteroids, the class of medicine most often used, suppress cytokine production broadly and quickly. Newer targeted medicines that block interleukin-6 directly have been studied precisely because that pathway seems central. Neither approach removes whatever started the process; both dampen the response while the condition runs its course, which in most people takes one to two years and in some considerably longer (NHS).

One more piece of the picture matters. PMR shares its inflammatory machinery with giant cell arteritis, an inflammation of medium and large arteries. The two conditions overlap often enough that every PMR consultation, in primary care or with a specialist, includes questions about headaches, jaw pain and vision.

What kind of doctor treats polymyalgia rheumatica?

In most health systems, the doctor who first recognizes PMR is a family physician or internist, and that same doctor manages the majority of straightforward cases from start to finish. NHS guidance describes exactly this pathway: diagnosis is made on the basis of symptoms, examination and blood tests, treatment is started, and referral to a specialist is reserved for particular circumstances.

The specialist in question is a rheumatologist, a physician trained in inflammatory and autoimmune conditions of joints, muscles, bones and blood vessels. Rheumatologists see PMR often, they see the conditions that imitate it even more often, and they are comfortable with the long, slow process of reducing anti-inflammatory treatment without provoking a relapse.

So the question “what kind of doctor should I see for polymyalgia rheumatica?” has a two-part answer. Start with your primary care clinician, because they can order the right blood tests today and can recognize the emergency signs of giant cell arteritis. Expect a rheumatologist to become involved if your case has any feature that makes the diagnosis less certain or the treatment less predictable. Those features are laid out in the next section.

Other specialists occasionally play a role. An ophthalmologist, an eye doctor, becomes essential if vision symptoms appear. A physical therapist can help restore shoulder and hip movement once inflammation is controlled. An orthopedic surgeon is rarely the right first stop, because PMR is a medical condition rather than a structural one, though people are sometimes sent that way when symptoms are mistaken for rotator cuff or hip joint problems.

The practical point is that PMR is a diagnosis of pattern recognition backed by blood tests, not a diagnosis that requires a specialist to make. What a specialist adds is judgment at the edges: when the pattern is incomplete, when the tests do not fit, or when treatment behaves unexpectedly.

Polymyalgia rheumatica: when to see a rheumatologist instead of staying with your GP

Referral is not a verdict on your primary care doctor. It is a recognition that certain presentations carry a higher chance of being something else, or of needing treatment that is harder to steer. The circumstances below are the ones most consistently flagged across NHS and specialist guidance as reasons to involve a rheumatologist, ideally early.

• Age under about 60 at onset. PMR before 50 is rare enough that other diagnoses become more likely (NHS).
• Inflammatory markers that do not fit: ESR and CRP that are normal, or that are extremely high. Both patterns widen the list of possible causes.
• Symptoms that are not the classic picture, for example pain confined to one side, prominent small-joint swelling in the hands, muscle weakness rather than stiffness, or marked weight loss.
• An incomplete response to initial treatment. Mayo Clinic notes that PMR typically improves dramatically within the first few days of corticosteroid treatment; if pain and stiffness are still largely unchanged after two to three weeks, the diagnosis deserves a second look.
• Repeated relapses whenever treatment is reduced, or an inability to reduce it over the expected timeline.
• Significant risk from long-term corticosteroids: existing osteoporosis, diabetes, glaucoma, poorly controlled blood pressure or a history of fractures.
• Any suspicion of giant cell arteritis, which is urgent rather than routine and is covered in its own section below.

There is a softer category, too. Some people simply want a specialist to confirm a diagnosis before committing to a year or more of medication with real side effects. That is a reasonable request, and many primary care clinicians will support it, though waiting times vary and treatment should not usually be delayed while a referral is pending.

What referral does not mean is that your care leaves primary care. In practice the two doctors share the work: the rheumatologist sets the strategy and sees you at intervals, while your regular doctor handles blood monitoring, bone health and the ordinary business of being a patient.

What labs are elevated with polymyalgia rheumatica? Reading your blood test results

There is no single blood test that proves PMR. What doctors look for is a pattern: evidence of inflammation, an absence of the markers that point to other diseases, and a clinical story that matches. The table summarizes what is typically checked and what the results usually show (MedlinePlus, Mayo Clinic, NHS).

Test	What it measures	Typical finding in PMR	Why it matters
ESR (erythrocyte sedimentation rate)	How fast red cells settle in a tube, a rough gauge of inflammation	Usually raised, sometimes markedly	Supports the diagnosis; also used to track response
CRP (C-reactive protein)	A liver protein produced in response to inflammation	Usually raised	Rises and falls faster than ESR, so it is useful for monitoring
Full blood count	Red cells, white cells, platelets	May show mild anemia of chronic inflammation	Also screens for blood disorders that can mimic PMR
Creatine kinase (CK)	An enzyme released when muscle is damaged	Normal	A raised CK points toward a true muscle disease instead
Rheumatoid factor and anti-CCP antibodies	Antibodies associated with rheumatoid arthritis	Usually negative	Positive results shift suspicion toward rheumatoid arthritis
Thyroid function	Thyroid hormone levels	Normal	An underactive thyroid can cause similar aches and fatigue
Kidney, liver and calcium tests	Organ function and bone chemistry	Usually normal	Baseline before treatment and a screen for other causes

Two caveats deserve emphasis. A small minority of people with genuine PMR have normal ESR and CRP at diagnosis, so normal inflammatory markers do not close the door, though they are one of the classic triggers for specialist referral. Conversely, raised markers are nonspecific: infection, other inflammatory conditions and some cancers raise them too. That is precisely why the blood work is read alongside the history rather than in isolation.

Doctors sometimes add a urine test to look for protein, and may check vitamin D and blood sugar before starting treatment, since corticosteroids affect both bone and glucose. Imaging is not routine, but ultrasound of the shoulders can be helpful when the diagnosis is uncertain.

Conditions that mimic PMR: what a rheumatologist is really ruling out

The reason specialists take uncertain cases seriously is that PMR has an unusually long list of impersonators, and several of them are treated very differently. When a rheumatologist sees a referral, this is the mental checklist being worked through.

Late-onset rheumatoid arthritis is the most common look-alike. In older adults it can begin with shoulder and hip stiffness rather than the textbook swollen knuckles, and it may respond to corticosteroids at first, which is why an early good response does not settle the question. Positive rheumatoid antibodies, persistent swelling in the small joints of the hands and feet, or symptoms that return the moment treatment is lowered all raise this possibility (Cleveland Clinic).

Inflammatory muscle diseases such as polymyositis cause weakness rather than stiffness, and the creatine kinase level is raised. Fibromyalgia causes widespread pain and fatigue but no inflammation on blood tests and no morning stiffness that lasts for an hour. An underactive thyroid produces aches, tiredness and weight gain, and a simple hormone test identifies it. Osteoarthritis of the shoulders and hips is common at this age and can coexist with PMR, muddying the picture.

Less common but more consequential are the conditions no one wants to miss. Some cancers, particularly blood cancers such as myeloma and lymphoma, can present with bone pain, fatigue, anemia and a high ESR. Infections that seed the heart valves or the spine can do the same. Statin-related muscle symptoms deserve a question about medication history. And giant cell arteritis, the closest relative of PMR, may be the actual diagnosis when headache or visual symptoms sit alongside the aches.

None of this is meant to alarm. The point is that the same handful of blood tests, a careful examination and a few pointed questions distinguish these possibilities in the great majority of cases. Where they do not, a specialist has access to imaging and to the experience of having seen the rare version before.

What will a rheumatologist do for PMR at the first visit?

The first appointment is mostly conversation and hands-on examination, and it can take longer than people expect. Expect to be asked, in detail, when the stiffness started, how long it lasts each morning, whether it is truly on both sides, what makes it better and worse, and whether anything else changed at the same time: appetite, weight, sleep, mood, temperature. You will be asked specifically about headaches, scalp tenderness, jaw pain when chewing and any visual disturbance, because those are the warning signs of giant cell arteritis.

The examination focuses on range of movement rather than strength. A rheumatologist will typically ask you to raise your arms, place your hands behind your head and behind your back, and rotate your hips, watching for the restricted, guarded movement characteristic of inflamed shoulder and hip linings. Muscle strength is usually normal in PMR, so real weakness is a clue pointing elsewhere. The small joints of the hands and feet are checked for swelling, the temples are felt for tender or thickened arteries, and the pulses in the arms may be compared.

Blood tests are reviewed and often repeated or extended. If the picture is unclear, ultrasound of the shoulders or hips may be arranged to look for the bursitis and tendon sheath inflammation typical of PMR. Very occasionally a PET scan, which highlights areas of active inflammation throughout the body, is used when large-vessel inflammation or an alternative diagnosis is suspected.

Then comes the plan. If PMR is confirmed, the rheumatologist will explain the expected shape of treatment, including how the initial response is judged, roughly how the gradual reduction is paced and what monitoring is needed for bones, blood sugar and blood pressure. If the diagnosis is not confirmed, you should leave with a clear explanation of what is being considered instead and what the next test will show. Either way, the decision about medication, and any change to it, rests with the prescribing clinician.

How is polymyalgia rheumatica treated, and how does the medicine actually work?

The mainstay of treatment is a corticosteroid, a synthetic version of the hormone cortisol that the adrenal glands make naturally. Corticosteroids switch off the genes that produce inflammatory cytokines, including interleukin-6, and they do it fast. That speed is diagnostic in itself: Mayo Clinic describes relief typically beginning within the first two or three days, and NHS guidance says most people feel much better within a few days of starting. A sluggish response is one of the clearest signals that something other than PMR may be going on.

The medicine controls the inflammation but does not switch off whatever is driving it, so treatment continues at a gradually reducing level while the condition burns itself out. NHS guidance gives a typical treatment duration of one to two years, with some people needing longer. The reduction is deliberately slow, guided by symptoms and inflammatory markers, because dropping too quickly is the commonest reason for relapse. Exactly how the reduction is paced is individual and belongs entirely to the prescribing clinician.

Long-term corticosteroid use carries well-documented risks: thinning of bones, raised blood sugar, weight gain, higher blood pressure, cataracts, thinner skin and mood changes (Mayo Clinic). For that reason treatment plans usually include bone protection measures, sometimes calcium and vitamin D and sometimes a bone-strengthening medicine, along with periodic blood pressure, glucose and eye checks. These are not optional extras; they are part of the treatment.

When corticosteroids cannot be reduced without relapse, or when side effects mount, a rheumatologist may discuss a steroid-sparing medicine. The most established option belongs to the class known as conventional disease-modifying antirheumatic drugs, with methotrexate the generic most often mentioned in guidelines. More recently, biologic medicines that block the interleukin-6 receptor have been studied in PMR. The evidence for both is more modest than for corticosteroids, and their use is a specialist decision weighed against each person’s circumstances.

Nonsteroidal anti-inflammatory painkillers are generally not effective enough to control PMR on their own (NHS), and this is worth knowing before self-treating for weeks.

Who is usually referred straight away, and who is usually asked to wait

Referral decisions are triage decisions, and it helps to see them from the doctor’s side of the desk. Three broad groups emerge.

The first group is sent urgently, often the same day. Anyone with symptoms suggesting giant cell arteritis belongs here: new persistent headache, tenderness over the temples or scalp, pain in the jaw or tongue when chewing, or any change in vision (NHS). This is not a rheumatology waiting-list referral but an emergency pathway, because untreated arterial inflammation can cause permanent sight loss. Treatment for suspected giant cell arteritis is typically started before the specialist confirms the diagnosis.

The second group is referred promptly but not urgently. This includes people under about 60, people whose blood tests are normal or unusually high, people with atypical features such as one-sided pain, swollen hand joints, weakness or marked weight loss, and people with medical conditions that make corticosteroids particularly risky. Many primary care clinicians start treatment in this group while the referral is being arranged, then adjust once specialist input arrives.

The third group, which is the majority, is usually asked to wait and see how treatment goes. A woman in her seventies with classic symmetrical shoulder and hip stiffness, an hour of morning stiffness, raised ESR and CRP and no warning signs fits the pattern closely enough that primary care management is appropriate. The plan for this group is conditional: it converts to a referral if the response to treatment is incomplete after a few weeks, if relapses recur, if the expected reduction stalls, or if side effects become a problem (NHS).

Being in the third group is good news rather than dismissal. It means your presentation is typical, your diagnosis is relatively secure and your treatment is expected to behave predictably. It also means you have a role: reporting honestly when symptoms return, attending monitoring blood tests and raising concerns early rather than waiting for the next scheduled review.

What the first days and weeks of treatment usually look like

The opening chapter of treatment is often startling. People who have struggled to get out of bed for weeks describe waking on the second or third morning and simply sitting up. Mayo Clinic frames this as relief within the first few days, and many patients call it the most dramatic response to a medicine they have ever experienced. Stiffness typically eases first, the deep ache follows, and energy and appetite return over the next week or two.

A follow-up review is usually arranged within the first few weeks, with repeat blood tests. Two things are being checked: that symptoms have improved substantially, and that ESR and CRP are falling. Both should move in the same direction. When they do, the diagnosis is considered confirmed by response, and the gradual reduction begins. When symptoms improve but blood markers do not, or vice versa, the clinician will want to understand why before proceeding.

The middle chapter is longer and quieter. Over the following months treatment is stepped down at intervals, usually with a check of symptoms and markers before each step. Some people sail through; others feel the stiffness nudge back at a particular level and need to hold there for a while. That pause is not failure. It is the process working as designed, and it is the point at which a rheumatologist is most likely to be brought in if not already involved.

Alongside the medicine, gentle movement matters. Shoulders and hips that have been guarded for weeks lose range, and a physical therapist can help restore it once the inflammation is controlled. Bone protection, blood pressure and glucose monitoring continue throughout.

The final chapter, for most people, is stopping treatment altogether after one to two years, sometimes longer (NHS). A minority relapse after stopping and need a further course. Relapse does not reset the clock to zero; it usually responds as quickly as the original episode did, and it is one more reason to keep the door to specialist advice open.

What causes flare-ups of polymyalgia rheumatica?

Flare-ups, or relapses, are common enough that they should be expected rather than feared. The best-documented cause is reducing corticosteroid treatment faster than the underlying inflammation has settled. Mayo Clinic notes that relapse is common when the medicine is lowered too quickly, and this is why reduction schedules are so cautious and why clinicians resist the understandable urge to “get off the steroids” as soon as symptoms disappear.

Beyond that, the evidence becomes thinner and the honest answer is that many flares have no identifiable trigger. Patients frequently link relapses to intercurrent infections, physical or emotional stress, poor sleep or a period of unusual exertion. These associations are plausible, because any of them can stimulate the immune system, but they have not been proven in controlled studies. A doctor who says “we don’t fully know why that happened” is being accurate, not evasive.

Two things are worth distinguishing from a true flare. The first is ordinary musculoskeletal pain. A sore shoulder after carrying shopping, or a stiff hip after a long drive, does not mean PMR has returned; a genuine relapse usually brings back the symmetrical pattern, the prolonged morning stiffness and often the fatigue. The second is the aching that some people feel as corticosteroids are withdrawn, which relates to the body’s own cortisol production catching up rather than to renewed inflammation. Blood tests help separate these, which is why it is better to report a suspected flare than to adjust anything yourself.

What causes flare-ups also depends on what is being called PMR. Someone whose “relapses” happen every time treatment is lowered, who never quite reaches a low level, or who develops swollen finger joints along the way may not have PMR at all but late-onset rheumatoid arthritis or another inflammatory condition. Persistent relapse is therefore one of the strongest reasons to ask about a rheumatology opinion if you do not already have one.

The practical advice is simple: keep a brief note of when symptoms change and what was happening at the time, and bring it to appointments. Patterns that are invisible day to day often become obvious on paper.

PMR and giant cell arteritis: the connection nobody should ignore

Giant cell arteritis, sometimes called temporal arteritis, is inflammation of the medium and large arteries, particularly those supplying the head and eyes. It shares age of onset, inflammatory markers and probably underlying mechanisms with PMR, and the two occur together often enough that they are sometimes described as different expressions of one disease. Cleveland Clinic and Mayo Clinic both note that a meaningful minority of people with PMR, commonly quoted as somewhere between one in ten and one in five, develop giant cell arteritis at some point, and the reverse overlap is even higher.

Why does this matter so much? Because inflammation in the arteries feeding the optic nerve can cut off its blood supply, and the resulting vision loss is usually permanent. NHS guidance on temporal arteritis is unambiguous that it needs urgent treatment. The window between the first visual symptoms and irreversible damage can be short.

The warning signs are distinctive, and every person with PMR should know them by heart: a new, persistent headache, often at the temples; tenderness of the scalp, sometimes noticed when brushing hair; pain in the jaw muscles when chewing that eases with rest; blurred, double or briefly lost vision in one eye; and sometimes fever, night sweats or a sore tongue (NHS). Any of these, in someone with known or suspected PMR, warrants same-day medical assessment, and vision symptoms warrant emergency care.

A rheumatologist assessing PMR will feel the temporal arteries, ask these questions directly and may arrange ultrasound of the arteries if there is any doubt. Diagnosis of giant cell arteritis may involve a small biopsy of the temporal artery under local anesthetic. Treatment uses higher levels of corticosteroids than PMR alone, and is started on suspicion rather than delayed for test results.

The message is not that PMR is dangerous. For most people it is a painful, treatable, self-limiting condition. The message is that PMR comes with a specific set of red flags that convert a routine situation into an urgent one, and knowing them is part of managing the condition well.

What people often get wrong about polymyalgia rheumatica

The first myth is that PMR is a muscle disease and that exercise, massage or stretching will fix it. The pain is felt in the muscles but generated in the joint linings and bursae, and no amount of stretching resolves synovial inflammation. Movement helps maintain range and is encouraged once treatment takes effect, but it is not a substitute.

The second is that a good response to corticosteroids proves the diagnosis. It strongly supports it, but late-onset rheumatoid arthritis, some other inflammatory conditions and even certain infections and cancers can improve temporarily on the same medicine. That is why doctors watch for the full pattern: fast improvement, falling blood markers and a reduction that proceeds without repeated relapse.

The third is that normal blood tests exclude PMR. A small minority of people have normal ESR and CRP at diagnosis, so normal results prompt more careful evaluation rather than dismissal (Mayo Clinic).

The fourth is that the medicine can be stopped as soon as the pain goes. Symptoms disappear within days; the underlying inflammation takes a year or two to settle (NHS). Stopping early is the most reliable way to bring symptoms back, and abrupt cessation after months of treatment can leave the body short of its own cortisol. Any change belongs with the prescribing clinician.

The fifth is that PMR is “just aging.” Pain and stiffness that arrive over days, affect both sides, keep someone in bed for an hour each morning and come with fatigue and weight loss are not normal at any age, and dismissing them delays treatment that works quickly.

The sixth, and perhaps the most consequential, is that a headache or a bit of jaw ache can wait until the next appointment. In PMR those symptoms may signal giant cell arteritis, and waiting risks sight. When in doubt, call the same day.

Finally, some people believe a rheumatologist referral means the case is serious or that their own doctor has failed. Neither is true. Referral reflects uncertainty or complexity, not severity, and shared care between a family doctor and a specialist is the norm rather than the exception for anything that lasts a year or more.

Questions to ask your care team

A PMR appointment covers a lot of ground quickly, and it is easy to leave with the prescription but without the plan. These questions are the ones patients most often wish they had asked, whether the person across the desk is a family doctor or a rheumatologist.

• How confident are you that this is PMR rather than one of the conditions that resemble it, and what would change your mind?
• Which of my blood results supported the diagnosis, and which ones will you use to track progress?
• How soon should I expect to feel better, and what should I do if I am not substantially improved by our next review?
• Roughly how long do you expect treatment to last in my case, and what will guide each reduction step?
• What symptoms would count as a flare, and how do you want me to report one?
• What are the specific warning signs of giant cell arteritis, and exactly who do I contact, day or night, if they appear?
• What are you doing to protect my bones, blood sugar, blood pressure and eyes during treatment, and which checks will happen when?
• Are there features of my case that would make you want a rheumatologist involved, now or later?
• Which of my other medicines or conditions interact with this treatment?
• Is there any role for physical therapy or a movement program once the inflammation is controlled?
• What should I do if I become unwell with an infection or need surgery while on this treatment?

Write the answers down or bring someone to listen. The most useful outcome of the conversation is not a list of facts but a clear sense of who is responsible for what: who monitors the blood tests, who decides on reductions, and who you call when something changes. If that is unclear at the end of the visit, ask again before you leave.

When to call your doctor: red-flag signs with PMR

Most of PMR management happens at scheduled reviews. A short list of situations should not wait for the next one.

Seek emergency care immediately if you develop any change in vision, including blurring, double vision, a curtain across part of the visual field or brief loss of sight in one eye. In someone with PMR these may indicate giant cell arteritis, and prompt treatment protects the other eye (NHS). Do not wait to see whether it settles.

Contact your doctor the same day for a new or persistent headache, especially over the temples; scalp tenderness; pain in the jaw or tongue when chewing; unexplained fever or drenching night sweats; or sudden weakness or numbness in a limb. These are the other recognized warning signs of arterial inflammation.

Arrange a prompt, though not emergency, appointment if your original symptoms have not clearly improved within two to three weeks of starting treatment, if they return during or after a reduction step, if you notice new swelling in the small joints of your hands or feet, or if you develop muscle weakness rather than stiffness. Each of these prompts a review of the diagnosis and, often, a specialist referral.

Call as well for problems that may relate to the medicine: black or bloody stools, severe abdominal pain, marked thirst and frequent urination, a fall or a new fracture, sudden mood changes, or signs of infection that seem worse than usual. Corticosteroids can mask the usual signs of infection, so a lower threshold is sensible.

Never stop corticosteroid treatment suddenly on your own, even if you feel well or worry about side effects. After weeks or months the body reduces its own cortisol production, and abrupt withdrawal can cause serious illness. Raise concerns with the prescribing clinician, who can adjust safely.

Every decision about testing, referral and treatment sits with your treating team. This article is a map of the territory, not a substitute for the conversation.

Frequently asked questions

What kind of doctor should I see for polymyalgia rheumatica?

Start with your primary care physician or internist, who can recognize the pattern, order ESR and CRP and other blood tests, and begin treatment. A rheumatologist, a specialist in inflammatory joint and autoimmune conditions, is usually involved when the diagnosis is uncertain, symptoms are atypical, blood tests do not fit, treatment does not work as expected or relapses recur. Any vision symptoms need urgent care, often through an eye specialist as well.

What does a rheumatologist do for PMR that a family doctor cannot?

Mainly, a rheumatologist brings experience with the conditions that imitate PMR, such as late-onset rheumatoid arthritis, inflammatory muscle disease and giant cell arteritis, and access to tools like joint ultrasound when the picture is unclear. They also manage difficult treatment courses: repeated relapses, stalled reductions, significant steroid side effects and the decision about whether a steroid-sparing medicine is appropriate. For straightforward cases, primary care management is standard and appropriate.

What labs are elevated with polymyalgia rheumatica?

The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), both general markers of inflammation, are usually raised. A full blood count may show mild anemia. Creatine kinase, a muscle enzyme, is typically normal, and rheumatoid factor and anti-CCP antibodies are usually negative. Thyroid, kidney, liver and calcium tests are checked to exclude other causes and to provide a baseline before treatment (MedlinePlus, Mayo Clinic).

Can I have polymyalgia rheumatica with normal blood test results?

Yes, although it is uncommon. A small minority of people with PMR have normal ESR and CRP at diagnosis, so normal results do not rule the condition out. They do, however, make the diagnosis less certain and broaden the list of alternatives, which is one of the recognized reasons to involve a rheumatologist. In these cases the clinical pattern, the response to treatment and sometimes shoulder ultrasound carry more weight.

What causes flare-ups of polymyalgia rheumatica?

The best-documented cause is reducing corticosteroid treatment faster than the underlying inflammation has settled, which is why reduction schedules are slow and guided by symptoms and blood markers (Mayo Clinic). Many patients also link flares to infections, stress or unusual exertion; these associations are plausible but not proven. Repeated relapses at every reduction step can also mean the diagnosis is something other than PMR and deserve specialist review.

How quickly should polymyalgia rheumatica respond to treatment?

Most people notice marked improvement within the first few days of starting corticosteroids, with Mayo Clinic describing relief typically within two or three days and NHS guidance saying most people feel much better within a few days. Fatigue and appetite usually recover over the following weeks. If pain and stiffness are still largely unchanged after two to three weeks, the diagnosis should be revisited rather than assumed.

How long does polymyalgia rheumatica last?

PMR is generally self-limiting, but slowly. NHS guidance gives a typical treatment duration of one to two years, with some people needing longer, and a minority relapse after stopping and need a further course. The exact course is individual and cannot be predicted at the start. Throughout that time, decisions about how quickly to reduce treatment belong with the prescribing clinician, guided by symptoms and inflammatory markers.

Is polymyalgia rheumatica the same as fibromyalgia?

No. Fibromyalgia causes widespread pain and fatigue without inflammation: blood markers are normal and morning stiffness, if present, is brief. PMR is an inflammatory condition with raised ESR and CRP in most cases, symmetrical shoulder and hip stiffness that lasts well over 45 minutes each morning, and a rapid response to corticosteroids (NHS). The distinction matters because the treatments are entirely different, and one of the roles of a rheumatologist is telling them apart.

Do I need to see a rheumatologist for polymyalgia rheumatica if I am already improving?

Usually not, if your presentation was typical, your blood tests supported the diagnosis, you improved quickly and there are no warning signs. Primary care management is standard for this group. Referral becomes appropriate if symptoms return during reductions, if the reduction stalls, if side effects become a problem, or if any features such as hand joint swelling or normal inflammatory markers make the diagnosis less certain.

What symptoms with PMR mean I should get urgent help?

Any change in vision, a new persistent headache, tenderness over the scalp or temples, pain in the jaw when chewing, or a sore tongue may indicate giant cell arteritis, which can cause permanent sight loss without prompt treatment (NHS). Vision symptoms need emergency care; the others need same-day assessment. Also seek prompt advice for black stools, severe abdominal pain, signs of serious infection or a fall while on corticosteroid treatment.

References

• NHS: Polymyalgia rheumatica
• NHS: Temporal arteritis (giant cell arteritis)
• MedlinePlus Medical Encyclopedia: Polymyalgia rheumatica

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.